Non-vascular Stents Market Size & Growth Forecast 2027–2036, By Segments (End Use, Type), Regional Demand Trends (North America, Asia Pacific, Europe), Key Country Insights (U.S., Japan, South Korea, Germany, France, Italy), and Competitive Landscape
Market Size and Growth Outlook
Non-vascular Stents Market size stood at USD 1.9 billion in 2026 and is predicted to grow at a 4.56% CAGR from 2027 to 2036, attaining USD 2.97 billion by 2036. The industry revenue for 2027 is estimated at USD 1.97 billion.
Get more details on this report
Request Free Sample ReportNon-vascular Stents Market Intelligence Snapshot
Regional Market Dynamics
- North America leads due to high procedural volumes, mature hospital infrastructure, and strong clinical familiarity with minimally invasive stenting across gastrointestinal and urological applications.
- Asia Pacific grows at 5.59% CAGR driven by expanding access to interventional care and rising adoption of minimally invasive procedures across high-volume clinical settings.
Segment Momentum
- Hospitals lead the market because they manage complex stent procedures requiring multidisciplinary care, advanced imaging, and post-procedure monitoring, making them the primary setting for higher-acuity non-vascular stent interventions.
- Esophageal Stents are growing fastest as demand increases for minimally invasive procedures that restore swallowing function and relieve obstruction through targeted, procedure-specific stent solutions.
Market Expansion Drivers
- Rising geriatric population and chronic disease prevalence increasing non-vascular stent demand.
- Expanding clinical trials and surgical volumes supporting procedural adoption of stents.
- Advancements in minimally invasive endoscopic procedures expanding stent utilization in outpatient care.
Leading Market Participants
- Major players in the non-vascular stents market include Medtronic plc (Ireland), Boston Scientific Corporation (United States), Becton, Dickinson and Company (United States), Cook Medical LLC (United States), CONMED Corporation (United States), ELLA-CS, s.r.o. (Czech Republic), Glaukos Corporation (United States), Hobbs Medical, Inc. (United States), Merit Medical Systems, Inc. (United States).
Global Market Forecast Snapshot
Market Outlook
- 2026 Market Size: USD 1.9 billion
- 2027 Estimated Market Size: USD 1.97 billion.
- Projected Market Size: USD 2.97 billion by 2036
- Growth Forecast: 4.56% CAGR (2027-2036)
Regional and Segment Outlook
- Leading Regional Market: North America
- High-Growth Regional Hub: Asia Pacific
- Core Revenue Segment: Hospitals (End Use) | Gastrointestinal Stents (Type)
- Emerging Opportunity Segment: Ambulatory Care Centers (ACS) (End Use) | Esophageal Stents (Type)
Market Growth Drivers and Industry Trends
Rising geriatric population and chronic disease prevalence increasing non-vascular stent demand
The expanding elderly population and increasing burden of chronic conditions are contributing to greater procedural requirements, which will support the non-vascular stents market across multiple therapeutic applications. Aging patients are more likely to experience gastrointestinal, biliary, respiratory, and other conditions that can cause narrowing or obstruction requiring mechanical support. Non-vascular stents can help maintain the openness of affected passages and facilitate minimally invasive management of these conditions. As healthcare systems increasingly focus on treating age-related and chronic disorders while reducing procedural burden, the availability of stenting options suited to different anatomical and clinical requirements is becoming increasingly important.
Expanding clinical trials and surgical volumes supporting procedural adoption of stents
Growing clinical research activity and increasing procedure volumes are strengthening the non-vascular stents market by generating broader clinical experience with stent-based interventions across different applications. Clinical trials can support the evaluation of new stent designs, materials, deployment methods, and therapeutic indications, while higher surgical volumes create greater opportunities for physicians to incorporate stenting into routine treatment pathways. Continued procedural experience can also improve familiarity among healthcare professionals and support the refinement of patient selection and placement techniques. The combination of clinical evidence development and expanding intervention volumes is increasing the role of stents in the management of non-vascular obstructions.
Advancements in minimally invasive endoscopic procedures expanding stent utilization in outpatient care
Technological progress in endoscopic intervention is opening additional opportunities for the non-vascular stents market by enabling physicians to manage certain conditions through less invasive procedures. Modern endoscopic techniques can provide direct access to affected anatomical areas while reducing the need for more invasive surgical approaches, making stent placement increasingly compatible with procedural settings outside traditional inpatient surgery. Improvements in visualization, delivery systems, and deployment techniques can also support more precise positioning and efficient intervention. As healthcare providers place greater emphasis on shorter recovery periods, procedural efficiency, and reduced hospitalization requirements, stent-based endoscopic treatments are becoming more relevant in outpatient and ambulatory care pathways.
| Growth Driver | Impact on CAGR | Regulatory Influence | Geographic Relevance | Adoption Rate | Impact Timeline |
|---|---|---|---|---|---|
| Rising geriatric population and chronic disease prevalence increasing non-vascular stent demand | 2.00% | High | North America, Europe | High | Near Term |
| Expanding clinical trials and surgical volumes supporting procedural adoption of stents | 1.80% | High | North America, Europe | Medium | Mid Term |
| Advancements in minimally invasive endoscopic procedures expanding stent utilization in outpatient care | 1.50% | High | Asia Pacific, North America | Emerging | Long Term |
Unlock insights tailored to your business with our bespoke market research solutions.
Click to get your customized report now.
Regional Demand Dynamics
North America (Largest Region)
North America held the largest share of the non-vascular stents market in 2026, supported by advanced healthcare infrastructure, established interventional treatment capabilities, and broad access to specialized medical technologies. Growing demand for minimally invasive procedures is encouraging the use of stents across gastrointestinal, biliary, and other non-vascular applications. Strong clinical expertise, sophisticated hospital systems, and continued adoption of innovative interventional devices further support the region’s position, while increasing emphasis on less invasive treatment approaches is sustaining demand.
Asia Pacific (Fastest-Growing Region)
Asia Pacific is the fastest-growing region in the non-vascular stents market, driven by expanding healthcare infrastructure, improving access to advanced medical procedures, and rising awareness of minimally invasive treatment options. Increasing healthcare expenditure and modernization of hospitals are creating broader opportunities for interventional devices. Growing patient demand for less invasive therapies, together with improvements in specialist care and diagnostic capabilities, is supporting greater adoption of non-vascular stents across the region.
| Parameter | North America | Asia Pacific | Europe | Latin America | MEA |
|---|---|---|---|---|---|
| Innovation Hub i Scale Nascent Developing Advanced | |||||
| Cost-Sensitive Region i Scale Low Medium High | |||||
| Regulatory Environment i Scale Restrictive Neutral Supportive | |||||
| Demand Drivers i Scale Weak Moderate Strong | |||||
| Development Stage i Scale Emerging Developing Developed | |||||
| Adoption Rate i Scale Low Medium High | |||||
| New Entrants / Startups i Scale Sparse Moderate Dense | |||||
| Macro Indicators i Scale Weak Stable Strong |
Key Country Insights
Germany 🇩🇪
Precision Clinical ApplicationsGermany’s non-vascular stents market reflects strong adoption of advanced medical solutions within specialized hospital environments. Providers focus on durable devices, procedural accuracy, and innovations that support complex interventions while maintaining high standards for patient care and device performance.
France 🇫🇷
Specialized Treatment SolutionsFrance’s non-vascular stents market centers on advanced clinical applications requiring effective and reliable implantable devices. Healthcare providers prioritize solutions that support minimally invasive procedures, enhance therapeutic outcomes, and integrate with specialized care pathways across hospitals and clinics.
Italy 🇮🇹
Hospital Procedure SupportItaly’s non-vascular stents market is driven by healthcare demand for dependable devices used in complex therapeutic procedures. Hospitals focus on solutions that improve intervention quality, simplify clinical workflows, and provide effective support for gastrointestinal and airway-related treatments.
Japan 🇯🇵
Aging Care TechnologiesJapan’s non-vascular stents market is influenced by increasing demand for minimally invasive treatment approaches in digestive and respiratory care. Medical institutions emphasize dependable devices that support complex procedures, improve patient comfort, and align with evolving healthcare needs.
South Korea 🇰🇷
Procedure Innovation FocusSouth Korea’s non-vascular stents market is shaped by expanding adoption of advanced endoscopic and interventional procedures. Hospitals seek innovative stent technologies that improve treatment flexibility, support physician efficiency, and address growing demand for specialized medical interventions.
United States 🇺🇸
Advanced Medical DevicesThe U.S. non-vascular stents market is supported by demand for minimally invasive interventions across gastrointestinal, airway, and urological procedures. Healthcare providers prioritize reliable stent designs, improved patient outcomes, and technologies that enhance procedural efficiency in specialized clinical settings.
Segment Leadership and Growth Trends
Non-vascular Stents Market Share (%), by End Use, 2026
Go beyond the chart, access full insights & data tables
Request Free Sample ReportEnd Use Segment Analysis: Hospitals (Largest Segment) vs Ambulatory Care Centers (ACS) (Fastest-Growing Segment)
Hospitals held the largest share of the non-vascular stents market in 2026, supported by their role in managing complex gastrointestinal, airway, and other non-vascular conditions requiring specialized interventional procedures. Hospitals provide access to advanced diagnostic infrastructure, multidisciplinary clinical teams, and procedural facilities needed for stent placement and patient monitoring. The concentration of specialized care within hospital settings continues to support their position, particularly for patients requiring complex interventions or comprehensive post-procedure management.
Ambulatory care centers (ACS) are gaining adoption as healthcare systems increasingly emphasize convenient, efficient, and less resource-intensive procedural care. Advances in minimally invasive techniques and improvements in patient selection can enable selected non-vascular stent procedures to be performed outside traditional inpatient environments. Greater focus on reducing hospital resource utilization, improving patient convenience, and expanding outpatient treatment capacity is supporting the increasing role of ambulatory care settings.
Type Segment Analysis: Gastrointestinal Stents (Largest Segment) vs Esophageal Stents (Fastest-Growing Segment)
The gastrointestinal stents segment represented the largest share of the non-vascular stents market in 2026. Its leading position is supported by the broad clinical need to restore or maintain gastrointestinal passage in patients experiencing obstructions and other conditions affecting digestive tract function. Stents provide a minimally invasive option for improving luminal patency and supporting symptom management, making them an important component of interventional gastrointestinal care. Increasing adoption of minimally invasive procedures and improvements in stent design continue to support demand for gastrointestinal stenting solutions.
Esophageal stents are expanding as clinicians increasingly use minimally invasive approaches to manage esophageal obstruction and related complications. Improvements in stent design, deployment techniques, and patient management are helping support more effective treatment while reducing the need for more invasive interventions in appropriate cases. Growing emphasis on rapid symptom relief, improved swallowing function, and less invasive treatment pathways is contributing to greater adoption of esophageal stenting within specialized care settings.
| Segment | Sub-Segment | Largest Segment | Fastest Growing |
|---|---|---|---|
| End Use | Hospitals, Ambulatory Care Centers (ACS), Specialty Clinics | Hospitals | Ambulatory Care Centers (ACS) |
| Type | Gastrointestinal Stents, Biliary, Duodenal, Colonic, Pancreatic, Esophageal Stents, Pulmonary (Airway) Stents, Silicone Airway, Metallic Airway, Urological Stents, Others | Gastrointestinal Stents | Esophageal Stents |
Competitive Landscape and Market Positioning
Prominent players in the non-vascular stents market:
1. Medtronic plc (Ireland)
2. Boston Scientific Corporation (United States)
3. Becton Dickinson and Company (United States)
4. Cook Medical LLC (United States)
5. CONMED Corporation (United States)
6. ELLA-CS s.r.o. (Czech Republic)
7. Glaukos Corporation (United States)
8. Hobbs Medical Inc. (United States)
9. Merit Medical Systems Inc. (United States)
The non-vascular stents market is advancing through innovations in minimally invasive device design and material engineering. Frequent introduction of improved stent solutions is enhancing procedural outcomes and patient recovery. Collaborative efforts with healthcare systems are supporting broader adoption of advanced stent technologies.
| Company | Market Share | Company Revenue | Revenue CAGR (%) | Product Portfolio | Geographic Presence | Innovation / R&D Focus | Strategic Developments |
|---|---|---|---|---|---|---|---|
| Medtronic plc (Ireland) | |||||||
| Boston Scientific Corporation (United States) | |||||||
| Becton Dickinson and Company (United States) | |||||||
| Cook Medical LLC (United States) | |||||||
| CONMED Corporation (United States) | |||||||
| ELLA-CS s.r.o. (Czech Republic) | |||||||
| Glaukos Corporation (United States) | |||||||
| Hobbs Medical Inc. (United States) | |||||||
| Merit Medical Systems Inc. (United States). |
Industry Development/News
| Company Name | Date | Key Development |
|---|---|---|
| Cook Medical | Mar-24 | Cook Medical and Getinge signed a commercial distribution agreement for the iCast covered stent system in the United States. The collaboration aims to expand patient access to the device across relevant clinical settings for vascular and endovascular treatment applications. |
| BD (Becton, Dickinson and Company) | Mar-24 | BD initiated first patient enrollment in its AGILITY investigational device exemption study evaluating the BD Vascular Covered Stent for peripheral arterial disease treatment. The study assesses safety and effectiveness to support clinical validation and potential regulatory advancement. |
| Becton, Dickinson and Company | Mar-24 | Becton, Dickinson and Company initiated first patient enrollment in the AGILITY investigational device exemption study in March 2024. The clinical trial evaluates the BD Vascular Covered Stent for treatment of peripheral arterial disease, supporting regulatory validation and clinical evidence generation for next-generation endovascular stent technologies. |
Customize Your Report
Explore examples of how this report can be tailored to different research needs, including custom segments, additional topics or chapters, and related reports. Click a section of the wheel or its numbered marker to explore the available options.
Non-vascular Stents Market — Custom Segments
| Segment | Sub-Segment |
|---|---|
| Stent Material | Metal Stents, Silicone Stents, Polymer Stents, Biodegradable Stents |
| Placement Duration | Temporary Stents, Short-Term Stents, Long-Term Stents, Permanent Stents |
| Procedure Type | Endoscopic Stenting, Bronchoscopic Stenting, Ureteroscopic Stenting, Percutaneous Stenting |
Non-vascular Stents Market — Custom TOC
| Custom Chapter | Custom Details |
|---|---|
| Clinical Adoption Barrier Assessment |
|
| Emerging Application Opportunity Mapping |
|
| Reimbursement and Healthcare Economics Analysis |
|
Need a different cut of the data?
Request Custom ResearchWhat is the current revenue of the non-vascular stents market?
How is the non-vascular stents industry size expected to evolve during the forecast period?
How are demographic and chronic disease trends influencing demand in the non-vascular stents market?
How are minimally invasive procedures reshaping stent adoption in the non-vascular stents market?
Why do hospitals lead the non-vascular stents market?
Why are Esophageal Stents the fastest-growing type segment?
Why does North America lead the non-vascular stents market?
What is driving growth in the Asia Pacific non-vascular stents market?
Which companies are driving growth in the non-vascular stents landscape?
Our Clients
"The team took the time to understand our specific business needs and delivered a report that was well aligned with our objectives. Their expertise and understanding of the industry were clearly reflected in the quality and relevance of the insights provided."
Siemens Healthcare
"Our experience in acquiring the research report has been excellent. The depth of analysis, and actionable insights provided have been extremely valuable in supporting our ongoing R&D efforts."
GC Biopharma
"The report offered a comprehensive view of the market trends. The in-depth segmentation and analysis of emerging opportunities gave us a better understanding of the market."
Medtronic
Our Research Team & Methodology
Every Fundamental Business Insights report is built by a dedicated vertical research team, validated through a structured primary-and-secondary methodology, and reviewed for accuracy before it reaches you.
Research Team Overview
Prepared by the Healthcare & Medical Devices Research Team
Delivery
Published
Demand
Available
Support
Trust & Compliance
Research Domains
10 coverage areasResearch Intelligence
| Source | Reference |
|---|---|
| World Health Organization (WHO) | www.who.int |
| U.S. Food & Drug Administration (FDA) | www.fda.gov |
| European Medicines Agency (EMA) | www.ema.europa.eu |
| Centers for Disease Control and Prevention (CDC) | www.cdc.gov |
| National Institutes of Health (NIH) | www.nih.gov |
| National Center for Biotechnology Information (NCBI) | www.ncbi.nlm.nih.gov |
| PubMed | pubmed.ncbi.nlm.nih.gov |
| ClinicalTrials.gov | clinicaltrials.gov |
| International Organization for Standardization (ISO) | www.iso.org |
| ASTM International | www.astm.org |
| Advanced Medical Technology Association (AdvaMed) | www.advamed.org |
| Medical Device Innovation Consortium (MDIC) | mdic.org |
| Biotechnology Innovation Organization (BIO) | www.bio.org |
| International Federation of Pharmaceutical Manufacturers & Associations (IFPMA) | www.ifpma.org |
| U.S. Pharmacopeia (USP) | www.usp.org |
| European Directorate for the Quality of Medicines & HealthCare (EDQM) | www.edqm.eu |
| World Organisation for Animal Health (WOAH) | www.woah.org |
| American Hospital Association (AHA) | www.aha.org |
| OECD Health | www.oecd.org/health |
| World Bank Data | data.worldbank.org |
Research Workflow & Quality Assurance
Data Collection
Verified information gathered through primary and secondary research.
Data Triangulation
Cross-validation using multiple independent data sources.
Forecast Modelling
Market estimates developed using historical trends and analytical models.
Analyst Validation
Findings reviewed by domain experts for accuracy and consistency.
Editorial & Quality Review
Final editorial, quality, and compliance checks before publication.
Final Publication
Released after successful completion of the internal review process.
Report Coverage
📊 Market Assessment
- Market Size & Forecast
- Market Segmentation
- Regional Analysis
- Growth Drivers & Challenges
- Market Dynamics
🏢 Competitive Intelligence
- Competitive Landscape
- Company Profiles
- Competitive Benchmarking
- Mergers & Acquisitions
- Market Share Analysis or Key Company Strategies
🔍 Strategic Analysis
- Value Chain Analysis
- Porter's Five Forces
- PESTLE Analysis
- Pricing Trends
- Supply-Demand Analysis
🚀 Future Outlook
- Technology Landscape
- Regulatory Landscape
- Investment & Funding Landscape
- Emerging Opportunities
- Future Market Outlook
Have a question about this report or need a custom scope?
Request Customization